Abstract

Ran‐Binding protein M (RanBPM) is a nucleoplasmic protein. A recent study has shown that RanBPM is an inhibitor of ERK 1/2 signaling pathway by regulating c‐Raf stability. WNK is a serine/threonine kinase. Mutations in WNK1 and WNK4 cause pseudohypoaldosteronism type II (PHA II), characterized by hypertension, hyperkalemia and metabolic acidosis. Our previous study has shown that WNK4 inhibits NCC by activating ERK 1/2 signaling pathway. To determine whether WNK4 inhibits NCC through RanBPM‐dependent ERK 1/2 signaling pathway, we first investigated interaction between WNK4 and RanBPM using yeast‐two hybrid screening technique. We found that WNK4 interacted with RanBPM. RanBPM was also shown to prevent ERK 1/2 phosphorylation in response to EGF stimulation. When mouse distal convoluted cells (mDCT) were transfected with myc‐RanBPM, ERK 1/2 phosphorylation was decreased while NCC protein expression increased. When mDCT cells were transfected with siRNA RanBPM, ERK 1/2 phosphorylation was increased. These data suggest that 1) WNK4 interacts with RanBPM which is an inhibitor of ERK 1/2 phosphorylation; 2) RanBPM mediates NCC regulation likely through ERK1/2 signaling pathway.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.